Your browser doesn't support javascript.
loading
Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged rats.
Bennion, Douglas M; Isenberg, Jacob D; Harmel, Allison T; DeMars, Kelly; Dang, Alex N; Jones, Chad H; Pignataro, Megan E; Graham, Justin T; Steckelings, U Muscha; Alexander, Jon C; Febo, Marcelo; Krause, Eric G; de Kloet, Annette D; Candelario-Jalil, Eduardo; Sumners, Colin.
Afiliação
  • Bennion DM; Department of Physiology and Functional Genomics and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Isenberg JD; Department of Physiology and Functional Genomics and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Harmel AT; Department of Physiology and Functional Genomics and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • DeMars K; Department of Neuroscience and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Dang AN; Department of Physiology and Functional Genomics and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Jones CH; Department of Physiology and Functional Genomics and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Pignataro ME; Department of Physiology and Functional Genomics and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Graham JT; Department of Physiology and Functional Genomics and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Steckelings UM; Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
  • Alexander JC; Department of Psychiatry and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Febo M; Department of Psychiatry and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Krause EG; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America.
  • de Kloet AD; Department of Physiology and Functional Genomics and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Candelario-Jalil E; Department of Neuroscience and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Sumners C; Department of Physiology and Functional Genomics and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
PLoS One ; 12(7): e0180738, 2017.
Article em En | MEDLINE | ID: mdl-28671997

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Acidente Vascular Cerebral / Receptor Tipo 2 de Angiotensina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Acidente Vascular Cerebral / Receptor Tipo 2 de Angiotensina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos